ScholarIQanswers from OpenAlex & ORCID
Jonathan L. Wright
ResearcherPublications, citations & collaboration network
Jonathan L. Wright is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jonathan L. Wright have?
ScholarIQindexed works
Jonathan L. Wright has 638 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jonathan L. Wright have?
ScholarIQcitation count
Jonathan L. Wright has 31,775 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jonathan L. Wright?
ScholarIQh-index
Jonathan L. Wright has an h-index of 53 in OpenAlex.
What is the i10-index of Jonathan L. Wright?
ScholarIQi10-index
Jonathan L. Wright has an i10-index of 169 in OpenAlex.
What is the ORCID of Jonathan L. Wright?
ScholarIQorcid
The ORCID for Jonathan L. Wright is on the source record.
What is the OpenAlex record for Jonathan L. Wright?
ScholarIQopenalex
The OpenAlex for Jonathan L. Wright is on the source record.
What are the most-cited papers on Jonathan L. Wright?
ScholarIQmost cited works
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Rick Bangs, Rick Bangs, Jovan Begovic, Jason Brown, Mark K. Buyyounouski, Kevin Chan, Paul Chang, Arnold I. Chin, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Kaimakliotis, Shilajit Kundu, Subodh M. Lele, Amy Luckenbaugh, Jonathan Maldonado, Lin Mei, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle Richards, Steven Seyedin, Arlene O. Siefker‐Radtke, Tyler Stewart, Debasish Sundi, Umang Swami, Matthew Tollefson, Jonathan L. Wright, Carly J. Cassara, Bailee Sliker
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Homayoun Zargar, Patrick Espiritu, Adrian Fairey, Laura S. Mertens, Colin P. Dinney, Maria Carmen Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobsen, Nilay Gandhi, Joshua Griffin, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, David Youssef, Évanguelos Xylinas, Nicholas Campain, Wassim Kassouf, Marc Dall’Era, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Srikala S. Sridhar, John McGrath, Jonathan Aning, Shahrokh F. Shariat, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Jorge A. García, Andrew J. Stephenson, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Peter C. Black
Bladder Cancer, Version 3.2024
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Paul Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Z. Kaimakliotis, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles C. Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Tyler F. Stewart, Debasish Sundi, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Carly J. Cassara, Lisa A. Gurski